FDA Expects COVID Vaccines To Become An Annual Occurrence
According to a trio of prominent US Food and Drug Administration experts, the US may need to update its COVID-19 vaccines every year, and...
Camzyos, Possible Mega Cardiac Drug Given Green Light By FDA
Bristol Myers Squibb has gained approval for one of the year's most anticipated medications, following a brief delay in November. Camzyos, a drug developed...
Rinvoq From Abbvie Gets Fourth FDA Approval In Five Months
The pharma version of Fast and Furious has a new superhero. How else to characterise AbbVie's Rinvoq's breakthrough effectiveness? The immunology medicine received its...
FDA Seeks To Know How Prescription Drug Risks Are Weighed
The FDA's Office of Prescription Medicine Promotion (OPDP) intends to know how patients and doctors consider the risks and benefits of a new prescription medicine...
FDA clears Insulet’s next-generation Omnipod 5 wearable insulin delivery pump
Insulet added to its portfolio of life-changing diabetes management technologies when its Omnipod 5 received FDA clearance in January.
Omnipod 5 provides easier glucose management,...
Covaxin Phase 2 And 3 Trials Have Been Paused By The USFDA
The phase 2/3 clinical trials for Bharat Biotech's COVID-19 vaccine, Covaxin, in the United States have been halted by the US Food and Drug...
Major Success Factors For Clinical Development Organizations
Executive leaders at pharma and biotech companies are realising that an initial investment in a clinical trial associate's (CTA) career can impact and build...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...